Tumor development and the role of hereditary factors are highly correlated. A new class of biomarkers forecasts tumor progression and an entirely new way of understanding breast cancer origins. The gene sequences we inherit at conception can predict the type and severity of breast cancer we could develop decades later. The active involvement of gene … Read more
Breast cancer is the most common and second most fatal invasive cancer in the U.S. female population. Modern scientists have long studied the relationships between breast cancer risk and genetic and environmental factors, forming a general consensus that both types of factors play a role. A recent study conducted by Duke University researchers, entitled Cumulative … Read more
According to a recent study published in the online academic journal, eLife, over 50% of cancer patients who suffered from acute COVID-19 reported long COVID symptoms as far as seven months after their recovery. Female patients were more likely to report persistent long COVID symptoms, which include fatigue, gastrointestinal problems, myalgia (muscle aches and pains), … Read more
Breast cancer is the second most common cancer among women in the US, yet it is also possible for men to be diagnosed too. Although males receive only up to 1% of all breast cancer diagnoses, it is usually diagnosed at later, harder-to-treat stages, leading to approximately 500 men dying from it each year in … Read more
With the discovery of the BRCA2 gene in December 1995, researchers have been able to gain valuable insights and a better understanding of the role it plays in terms of the development of cancer. We inherit two copies of the BRCA2 gene in every one of our cells, one from our father and one from … Read more
With the discovery of the BRCA gene in December 1995, researchers have been able to gain valuable insights and a better understanding of the role it plays in terms of the development of cancer. We inherit two copies of the BRCA gene in every one of our cells, one from our father and one from … Read more
Cancer, a word everyone is familiar with, is a term for diseases that can affect any part of the body. These diseases are caused by the rapid, abnormal growth of cells that have the potential to extend beyond their normal boundaries into other parts of the body and organs. When diagnosed and treated in the … Read more
The world’s first RNA-based cancer drug has revealed promising results according to a peer-reviewed study in the scientific journal Advanced Materials. Overall, the report states that this new drug, tested on mice, has the potential to boost the effectiveness of both chemotherapy and immunotherapy – or, in this case, the combined treatments called chemo-immunotherapy. The … Read more
Every day, there are millions of women around the world who are at risk of getting ovarian cancer – many don’t know they are at risk, while a small percentage are unaware that they already have it. However, in the past few years, science has continued to lead the way through medical research and advancements … Read more
We are very passionate about sponsoring the Israel Cancer Association’s Prevention GENEration Program in collaboration with The Israel Hereditary Breast and Ovarian Cancer Consortium. The aim of the program is to reduce cancer morbidity in Israel by promoting research, prevention, early detection, treatment modalities, and means of rehabilitation. The High Rate of Individuals with the … Read more